chartexchange

Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire Inc. | Nov 12, 2026 7:00 AM EST

Zelsuvmi ® net product revenue grew 114% to $15.2 million during the third quarter of 2026 from $7.1 million in the third quarter of 2025

Read original article